))
AI-Powered Synthetic Biology for Drug Discovery with Aikium's Dr Venky Mysore
Manage episode 453099318 series 3203753
Content provided by Arun Trivedi. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Arun Trivedi or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
This YouTube transcript "AI with Arun Show" features an interview with Dr. Venkatesh Mysore, founder of Aikium, a biotechnology company using artificial intelligence (AI) and synthetic biology to revolutionize protein-based drug discovery. Aikium's innovative platform, YotaML², enables the high-throughput screening of trillions of proteins to identify potent and selective binders for various disease targets, particularly in oncology and neuroinflammatory disorders. The interview discusses Aikium's unique Seeker proteins, which offer a novel approach compared to traditional antibody-based therapies, and addresses challenges, ethical considerations, and the company's future plans, including the creation of a comprehensive catalog of protein binders. Dr. Mysore also shares insights into his personal journey in entrepreneurship and the evolving landscape of AI in biotechnology.
60 episodes
Share
